Have a personal or library account? Click to login

The status quo and prospect of transfer and shift in patients receiving hemodialysis in ChinaThis project was supported by Health and Family Planning Commission of Chongqing Medical Research Project (No. 2016ZDXM008), the outstanding young nurses in Second Hospital Affiliated to Chongqing Medical University (No. 201707), and Hospital Research and Construction Project of Chinese Medical Doctor Association (No. 201522).

Open Access
|Nov 2019

Abstract

Hemodialysis is the main alternative therapy for patients with end-stage renal disease; most of the hemodialysis centers in China are not designed together with the inpatient ward. During the hospitalization period, hemodialysis patients often move back and forth between wards and hemodialysis rooms because of the treatment needed. Hemodialysis patients are a special group of hospitalized patients, most of them are elderly patients. The overall basic diseases of the patients vary very much, and the cause of the disease is complex. Moreover, the chronic inflammation progresses slowly, and immune function declines. Some of the patient are seriously ill or even hav organ failure. All these factors affect the patients in general. Therefore, the transfer safety of patients during hospitalization is facing great challenges. The researchers reviewed the status of transshipment research in Chinese hemodialysis patients and laid the foundation for the research and development of related handover tools and perfect handover mode in the future.

DOI: https://doi.org/10.2478/FON-2019-0028 | Journal eISSN: 2544-8994 | Journal ISSN: 2097-5368
Language: English
Page range: 169 - 174
Submitted on: Jul 16, 2018
Accepted on: Nov 26, 2018
Published on: Nov 7, 2019
Published by: Shanxi Medical Periodical Press
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2019 Tian Zhang, Xiu-Ni Gan, Wei Tang, Min Zou, Ying Zhang, published by Shanxi Medical Periodical Press
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.